Nucleus Software Exports Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 4, 2025, 12:56 pm

Market Cap	3,170 Cr.
Current Price	1,184
High / Low	1,645/724
Stock P/E	19.5
Book Value	304
Dividend Yield	1.09 %
ROCE	27.5 %
ROE	20.5 %
Face Value	10.0
PEG Ratio	2.31

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Nucleus Software Exports Ltd

Competitors of Nucleus Software Exports Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
IDream Film Infrastructure Company Ltd	1.98 Cr.	132	132/89.3		303	0.00 %	%	%	10.0
I Power Solutions India Ltd	8.17 Cr.	18.4	18.4/12.4		7.82	0.00 %	11.2 %	16.4 %	10.0
Hypersoft Technologies Ltd	12.7 Cr.	30.0	30.0/15.2	60.6	5.69	0.00 %	20.6 %	9.07 %	10.0
Zensar Technologies Ltd	19,022 Cr.	837	985/536	29.3	179	1.54 %	22.0 %	17.0 %	2.00
Sonata Software Ltd	11,563 Cr.	412	764/286	27.2	60.8	1.92 %	29.1 %	27.3 %	1.00
Industry Average	137,495.13 Cr	992.67		56.87	167.18	0.77%	21.14%	19.37%	6.90

All Competitor Stocks of Nucleus Software Exports Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	153	129	130	169	206	207	205	204	210	195	202	206	229
Expenses	128	114	119	121	123	144	153	156	152	166	170	172	154
Operating Profit	25	15	11	48	83	63	52	48	58	29	32	33	74
OPM %	16%	11%	9%	28%	40%	30%	25%	23%	28%	15%	16%	16%	33%
Other Income	6	6	9	9	10	13	12	12	14	15	19	16	17
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	5	5	5	5	4	4	4	4	4	4	4	4	3
Profit before tax	26	16	15	52	89	72	60	56	68	40	47	45	88
Tax %	30%	31%	26%	26%	24%	25%	26%	26%	24%	24%	29%	22%	26%
Net Profit	18	11	11	38	68	54	45	41	52	30	33	35	65
EPS in Rs	6.83	4.02	4.12	14.32	25.27	20.01	16.65	15.43	19.47	11.28	12.35	13.06	24.19

Last Updated: May 31, 2025, 8:15 am

Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 229.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Dec 2024) to 229.00 Cr., marking an increase of 23.00 Cr..
For Expenses, as of Mar 2025, the value is 154.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 172.00 Cr. (Dec 2024) to 154.00 Cr., marking a decrease of 18.00 Cr..
For Operating Profit, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Dec 2024) to 74.00 Cr., marking an increase of 41.00 Cr..
For OPM %, as of Mar 2025, the value is 33.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Dec 2024) to 33.00%, marking an increase of 17.00%.
For Other Income, as of Mar 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Dec 2024) to 17.00 Cr., marking an increase of 1.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 88.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Dec 2024) to 88.00 Cr., marking an increase of 43.00 Cr..
For Tax %, as of Mar 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Dec 2024) to 26.00%, marking an increase of 4.00%.
For Net Profit, as of Mar 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Dec 2024) to 65.00 Cr., marking an increase of 30.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 24.19. The value appears strong and on an upward trend. It has increased from 13.06 (Dec 2024) to 24.19, marking an increase of 11.13.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:36 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	346	353	349	372	412	484	521	514	497	634	826	832
Expenses	278	287	318	319	353	405	427	384	460	478	606	664
Operating Profit	68	66	31	54	59	79	94	129	37	157	220	168
OPM %	20%	19%	9%	14%	14%	16%	18%	25%	7%	25%	27%	20%
Other Income	24	33	26	32	29	27	37	39	35	34	51	66
Interest	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	8	12	12	11	7	10	14	14	15	19	15	15
Profit before tax	83	87	44	74	80	96	117	154	56	171	256	219
Tax %	23%	25%	26%	11%	22%	23%	24%	23%	26%	25%	25%	26%
Net Profit	64	65	32	66	63	75	89	118	41	128	192	163
EPS in Rs	19.87	19.98	10.03	20.43	21.54	25.67	30.64	40.62	15.28	47.73	71.56	60.88
Dividend Payout %	30%	25%	50%	24%	37%	35%	29%	22%	46%	21%	17%	20%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	1.56%	-50.77%	106.25%	-4.55%	19.05%	18.67%	32.58%	-65.25%	212.20%	50.00%	-15.10%
Change in YoY Net Profit Growth (%)	0.00%	-52.33%	157.02%	-110.80%	23.59%	-0.38%	13.92%	-97.84%	277.45%	-162.20%	-65.10%

Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	10%
3 Years:	19%
TTM:	1%

Compounded Profit Growth
10 Years:	11%
5 Years:	14%
3 Years:	84%
TTM:	-2%

Stock Price CAGR
10 Years:	16%
5 Years:	35%
3 Years:	46%
1 Year:	-16%

Return on Equity
10 Years:	16%
5 Years:	18%
3 Years:	22%
Last Year:	20%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:36 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	32	32	32	32	29	29	29	29	27	27	27	26
Reserves	365	406	425	503	432	480	532	643	467	584	751	788
Borrowings	0	0	1	0	0	0	6	6	2	6	5	2
Other Liabilities	116	118	123	131	184	177	196	206	241	257	332	337
Total Liabilities	513	556	581	665	645	685	763	885	737	874	1,114	1,153
Fixed Assets	61	58	54	48	48	47	57	50	59	50	59	61
CWIP	1	1	1	0	0	0	0	1	0	1	1	0
Investments	224	170	245	441	387	424	475	635	480	525	649	641
Other Assets	228	328	281	176	210	214	231	200	198	298	406	451
Total Assets	513	556	581	665	645	685	763	885	737	874	1,114	1,153

Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 1.00 Cr..
For Reserves, as of Mar 2025, the value is 788.00 Cr.. The value appears strong and on an upward trend. It has increased from 751.00 Cr. (Mar 2024) to 788.00 Cr., marking an increase of 37.00 Cr..
For Borrowings, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 3.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 337.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 332.00 Cr. (Mar 2024) to 337.00 Cr., marking an increase of 5.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 1,153.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,114.00 Cr. (Mar 2024) to 1,153.00 Cr., marking an increase of 39.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 61.00 Cr., marking an increase of 2.00 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
For Investments, as of Mar 2025, the value is 641.00 Cr.. The value appears to be declining and may need further review. It has decreased from 649.00 Cr. (Mar 2024) to 641.00 Cr., marking a decrease of 8.00 Cr..
For Other Assets, as of Mar 2025, the value is 451.00 Cr.. The value appears strong and on an upward trend. It has increased from 406.00 Cr. (Mar 2024) to 451.00 Cr., marking an increase of 45.00 Cr..
For Total Assets, as of Mar 2025, the value is 1,153.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,114.00 Cr. (Mar 2024) to 1,153.00 Cr., marking an increase of 39.00 Cr..

Notably, the Reserves (788.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	66	37	33	95	77	56	75	115	58	50	222	151
Cash from Investing Activity +	-56	-15	7	-78	61	-28	-28	-126	159	-12	-197	-21
Cash from Financing Activity +	-10	-23	-36	-1	-135	-26	-34	-13	-213	-23	-30	-126
Net Cash Flow	0	-1	4	16	3	2	12	-24	3	15	-5	4

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	68.00	66.00	30.00	54.00	59.00	79.00	88.00	123.00	35.00	151.00	215.00	166.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	87	44	87	90	60	70	54	63	63	61	100	73
Inventory Days
Days Payable
Cash Conversion Cycle	87	44	87	90	60	70	54	63	63	61	100	73
Working Capital Days	19	-5	14	9	-43	-66	-51	-51	-58	-75	-14	-36
ROCE %	18%	21%	19%	10%	15%	16%	19%	21%	22%	6%	27%	32%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	67.59%	73.28%	73.28%	73.27%	73.27%	73.27%	73.26%	73.27%	73.26%	73.26%	73.26%	73.59%
FIIs	3.74%	2.85%	2.87%	2.61%	2.63%	4.20%	3.99%	3.69%	5.02%	5.65%	5.35%	5.62%
DIIs	0.00%	0.00%	0.00%	0.16%	0.00%	0.33%	0.34%	0.59%	1.65%	1.90%	2.10%	1.75%
Public	28.67%	23.88%	23.85%	23.96%	24.10%	22.20%	22.40%	22.45%	20.05%	19.18%	19.28%	19.02%
No. of Shareholders	47,223	38,713	38,394	38,175	37,852	31,606	31,742	33,318	30,418	29,900	36,281	45,592

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
WhiteOak Capital Flexi Cap Fund	113,333	0.63	16.66	113,333	2025-04-22 17:25:24	0%
ICICI Prudential Innovation Fund	65,999	0.3	9.7	65,999	2025-04-22 17:25:24	0%
WhiteOak Capital Mid Cap Fund	45,586	0.51	6.7	45,586	2025-04-22 17:25:24	0%
Quant Teck Fund	38,000	2.75	5.58	38,000	2025-04-22 17:25:24	0%
WhiteOak Capital Multi Cap Fund	25,166	0.71	3.7	25,166	2025-04-22 17:25:24	0%
WhiteOak Capital Large Cap Fund	11,472	0.46	1.69	11,472	2025-04-22 17:25:24	0%
WhiteOak Capital Balanced Advantage Fund	8,909	0.18	1.31	8,909	2025-04-22 17:25:24	0%
ICICI Prudential Technology Fund	6,651	0.01	0.98	6,651	2025-04-22 17:25:24	0%
WhiteOak Capital ELSS Tax Saver Fund	4,324	0.58	0.64	4,324	2025-04-22 17:25:24	0%
WhiteOak Capital Multi Asset Allocation Fund	1,716	0.1	0.25	1,716	2025-04-22 17:25:24	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	61.40	71.56	47.73	14.28	40.62
Diluted EPS (Rs.)	61.40	71.56	47.73	14.28	40.62
Cash EPS (Rs.)	67.53	77.01	54.73	21.03	45.39
Book Value[Excl.RevalReserv]/Share (Rs.)	309.24	290.41	228.11	184.38	231.41
Book Value[Incl.RevalReserv]/Share (Rs.)	309.24	290.41	228.11	184.38	231.41
Revenue From Operations / Share (Rs.)	316.08	308.72	237.00	185.73	176.84
PBDIT / Share (Rs.)	89.10	101.34	71.28	26.78	58.16
PBIT / Share (Rs.)	83.48	95.91	64.29	21.03	53.38
PBT / Share (Rs.)	83.19	95.55	63.91	20.73	52.96
Net Profit / Share (Rs.)	61.91	71.57	47.74	15.28	40.62
NP After MI And SOA / Share (Rs.)	61.91	71.57	47.74	15.28	40.62
PBDIT Margin (%)	28.18	32.82	30.07	14.41	32.88
PBIT Margin (%)	26.41	31.06	27.12	11.32	30.18
PBT Margin (%)	26.32	30.95	26.96	11.16	29.95
Net Profit Margin (%)	19.58	23.18	20.14	8.22	22.96
NP After MI And SOA Margin (%)	19.58	23.18	20.14	8.22	22.96
Return on Networth / Equity (%)	20.01	24.64	20.92	8.28	17.55
Return on Capital Employeed (%)	25.25	31.36	26.84	10.84	22.57
Return On Assets (%)	14.13	17.19	14.61	5.55	13.33
Asset Turnover Ratio (%)	0.73	0.83	0.74	0.56	0.56
Current Ratio (X)	1.93	2.07	2.07	2.09	3.11
Quick Ratio (X)	1.93	2.07	2.07	2.09	3.11
Dividend Payout Ratio (NP) (%)	0.00	13.97	14.66	42.58	7.38
Dividend Payout Ratio (CP) (%)	0.00	12.98	12.79	30.94	6.60
Earning Retention Ratio (%)	0.00	86.03	85.34	57.42	92.62
Cash Earning Retention Ratio (%)	0.00	87.02	87.21	69.06	93.40
Interest Coverage Ratio (X)	312.81	285.58	187.09	88.51	138.44
Interest Coverage Ratio (Post Tax) (X)	218.33	202.68	126.28	51.51	97.68
Enterprise Value (Cr.)	1988.60	3091.48	1658.15	1054.42	1353.67
EV / Net Operating Revenue (X)	2.39	3.74	2.61	2.12	2.64
EV / EBITDA (X)	8.48	11.40	8.69	14.71	8.01
MarketCap / Net Operating Revenue (X)	2.54	3.83	2.69	2.23	2.72
Retention Ratios (%)	0.00	86.02	85.33	57.41	92.61
Price / BV (X)	2.59	4.07	2.80	2.25	2.08
Price / Net Operating Revenue (X)	2.54	3.83	2.69	2.23	2.72
EarningsYield	0.07	0.06	0.07	0.03	0.08

After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
For Diluted EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
For Cash EPS (Rs.), as of Mar 25, the value is 67.53. This value is within the healthy range. It has decreased from 77.01 (Mar 24) to 67.53, marking a decrease of 9.48.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 316.08. It has increased from 308.72 (Mar 24) to 316.08, marking an increase of 7.36.
For PBDIT / Share (Rs.), as of Mar 25, the value is 89.10. This value is within the healthy range. It has decreased from 101.34 (Mar 24) to 89.10, marking a decrease of 12.24.
For PBIT / Share (Rs.), as of Mar 25, the value is 83.48. This value is within the healthy range. It has decreased from 95.91 (Mar 24) to 83.48, marking a decrease of 12.43.
For PBT / Share (Rs.), as of Mar 25, the value is 83.19. This value is within the healthy range. It has decreased from 95.55 (Mar 24) to 83.19, marking a decrease of 12.36.
For Net Profit / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
For PBDIT Margin (%), as of Mar 25, the value is 28.18. This value is within the healthy range. It has decreased from 32.82 (Mar 24) to 28.18, marking a decrease of 4.64.
For PBIT Margin (%), as of Mar 25, the value is 26.41. This value exceeds the healthy maximum of 20. It has decreased from 31.06 (Mar 24) to 26.41, marking a decrease of 4.65.
For PBT Margin (%), as of Mar 25, the value is 26.32. This value is within the healthy range. It has decreased from 30.95 (Mar 24) to 26.32, marking a decrease of 4.63.
For Net Profit Margin (%), as of Mar 25, the value is 19.58. This value exceeds the healthy maximum of 10. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.58. This value is within the healthy range. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
For Return on Networth / Equity (%), as of Mar 25, the value is 20.01. This value is within the healthy range. It has decreased from 24.64 (Mar 24) to 20.01, marking a decrease of 4.63.
For Return on Capital Employeed (%), as of Mar 25, the value is 25.25. This value is within the healthy range. It has decreased from 31.36 (Mar 24) to 25.25, marking a decrease of 6.11.
For Return On Assets (%), as of Mar 25, the value is 14.13. This value is within the healthy range. It has decreased from 17.19 (Mar 24) to 14.13, marking a decrease of 3.06.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.83 (Mar 24) to 0.73, marking a decrease of 0.10.
For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
For Quick Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.97 (Mar 24) to 0.00, marking a decrease of 13.97.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 12.98 (Mar 24) to 0.00, marking a decrease of 12.98.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.03 (Mar 24) to 0.00, marking a decrease of 86.03.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 87.02 (Mar 24) to 0.00, marking a decrease of 87.02.
For Interest Coverage Ratio (X), as of Mar 25, the value is 312.81. This value is within the healthy range. It has increased from 285.58 (Mar 24) to 312.81, marking an increase of 27.23.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 218.33. This value is within the healthy range. It has increased from 202.68 (Mar 24) to 218.33, marking an increase of 15.65.
For Enterprise Value (Cr.), as of Mar 25, the value is 1,988.60. It has decreased from 3,091.48 (Mar 24) to 1,988.60, marking a decrease of 1,102.88.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 3.74 (Mar 24) to 2.39, marking a decrease of 1.35.
For EV / EBITDA (X), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 11.40 (Mar 24) to 8.48, marking a decrease of 2.92.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 86.02 (Mar 24) to 0.00, marking a decrease of 86.02.
For Price / BV (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has decreased from 4.07 (Mar 24) to 2.59, marking a decrease of 1.48.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Nucleus Software Exports Ltd as of July 4, 2025 is: 982.79

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 4, 2025, Nucleus Software Exports Ltd is Overvalued by 16.99% compared to the current share price 1,184.00

Intrinsic Value of Nucleus Software Exports Ltd as of July 4, 2025 is: 1,065.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 4, 2025, Nucleus Software Exports Ltd is Overvalued by 10.00% compared to the current share price 1,184.00

Last 5 Year EPS CAGR: 8.43%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 18.83%, which is a positive sign. The stock has a low average Working Capital Days of -29.75, which is a positive sign. The company has higher reserves (531.33 cr) compared to borrowings (2.33 cr), indicating strong financial stability. The company has shown consistent growth in sales (511.67 cr) and profit (119.75 cr) over the years.	The stock has a high average Cash Conversion Cycle of 71.00, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
1. Net Profit Margin: 19.58%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 25.25% (Industry Average ROCE: 21.14%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 20.01% (Industry Average ROE: 19.37%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 218.33
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.93
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 19.5 (Industry average Stock P/E: 56.87)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Nucleus Software Exports Ltd. is a Public Limited Listed company incorporated on 09/01/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1989PLC034594 and registration number is 034594. Currently Company is involved in the business activities of Computer programming, consultancy and related activities. Company's Total Operating Revenue is Rs. 768.66 Cr. and Equity Capital is Rs. 26.33 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	33-35, Thyagraj Nagar Market, New Delhi Delhi 110003	investorrelations@nucleussoftware.com http://www.nucleussoftware.com

Management
Name	Position Held
Mr. S M Acharya	Chairman(NonExe.&Ind.Director)
Mr. Vishnu R Dusad	Managing Director
Mr. Anurag Mantri	Executive Director & CFO
Mr. Parag Bhise	Executive Director & CEO
Mr. Ravi Pratap Singh	Executive Director
Dr. Ritika Dusad	Executive Director
Mr. Prithvi Haldea	Ind. Non-Executive Director
Mrs. Elaine Mathias	Ind. Non-Executive Director
Prof. Trilochan Sastry	Ind. Non-Executive Director
Ms. Yasmin Javeri Krishan	Ind. Non-Executive Director
Mr. P C Kandpal	Ind. Non-Executive Director
Mr. Shekar Viswanathan	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Nucleus Software Exports Ltd?

Nucleus Software Exports Ltd's intrinsic value (as of 04 July 2025) is 982.79 — 16.99% lower the current market price of 1,184.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,170 Cr. market cap, FY2025-2026 high/low of 1,645/724, reserves of 788 Cr, and liabilities of 1,153 Cr.

What is the Market Cap of Nucleus Software Exports Ltd?

The Market Cap of Nucleus Software Exports Ltd is 3,170 Cr..

What is the current Stock Price of Nucleus Software Exports Ltd as on 04 July 2025?

The current stock price of Nucleus Software Exports Ltd as on 04 July 2025 is 1,184.

What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is ₹1,645/724.

What is the Stock P/E of Nucleus Software Exports Ltd?

The Stock P/E of Nucleus Software Exports Ltd is 19.5.

What is the Book Value of Nucleus Software Exports Ltd?

The Book Value of Nucleus Software Exports Ltd is 304.

What is the Dividend Yield of Nucleus Software Exports Ltd?

The Dividend Yield of Nucleus Software Exports Ltd is 1.09 %.

What is the ROCE of Nucleus Software Exports Ltd?

The ROCE of Nucleus Software Exports Ltd is 27.5 %.

What is the ROE of Nucleus Software Exports Ltd?

The ROE of Nucleus Software Exports Ltd is 20.5 %.

What is the Face Value of Nucleus Software Exports Ltd?

The Face Value of Nucleus Software Exports Ltd is 10.0.